Predictive Oncology Inc. — Director's Dealing 2018

Jul 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Precision Therapeutics Inc. (AIPT)
CIK: 0001446159
Period of Report: 2018-06-30

Reporting Person: ENGLE J MELVILLE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-30	Stock Options (right to buy)	$1.13	A	4425	Acquired	2028-06-30	Common Stock (4425)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct